Cytogenetic Response To Low-Dose 5-Aza-2'-Deoxycytidine (Dac) In Poor-Risk Myelodysplastic Syndromes (Mds) - Phase Ii Study Results.

BLOOD(1997)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要